Alentis Therapeutics

Alentis Therapeutics the Claudin-1 Company is on a mission to treat cancer and reverse fibrosis. To this end we are rapidly advancing a clinical pipeline of anti-Claudin-1 monoclonal antibodies. Our team is committed to unlocking the broad potential of our therapeutic target Claudin-1

Alentis Therapeutics the Claudin-1 Company is on a mission to treat cancer and reverse fibrosis. To this end we are rapidly advancing a clinical pipeline of anti-Claudin-1 monoclonal antibodies. Our team is committed to unlocking the broad potential of our therapeutic target Claudin-1

Alentis Therapeutics the Claudin-1 Company is on a mission to treat cancer and reverse fibrosis. To this end we are rapidly advancing a clinical pipeline of anti-Claudin-1 monoclonal antibodies. Our team is committed to unlocking the broad potential of our therapeutic target Claudin-1

Alentis Therapeutics the Claudin-1 Company is on a mission to treat cancer and reverse fibrosis. To this end we are rapidly advancing a clinical pipeline of anti-Claudin-1 monoclonal antibodies. Our team is committed to unlocking the broad potential of our therapeutic target Claudin-1

The Bioanalytical Expert is responsible for providing scientific leadership and operational oversight for bioanalytical activities supporting the development of the companys therapeutic candidates. Reporting to the Vice President Clinical Pharmacology this role serves as the subject m

The Bioanalytical Expert is responsible for providing scientific leadership and operational oversight for bioanalytical activities supporting the development of the companys therapeutic candidates. Reporting to the Vice President Clinical Pharmacology this role serves as the subject m

Alentis Therapeutics the Claudin-1 Company is on a mission to treat cancer and reverse fibrosis. To this end we are rapidly advancing a clinical pipeline of anti-Claudin-1 monoclonal antibodies. Our team is committed to unlocking the broad potential of our therapeutic target Claudin-1

Alentis Therapeutics the Claudin-1 Company is on a mission to treat cancer and reverse fibrosis. To this end we are rapidly advancing a clinical pipeline of anti-Claudin-1 monoclonal antibodies. Our team is committed to unlocking the broad potential of our therapeutic target Claudin-1

The Bioanalytical Expert is responsible for providing scientific leadership and operational oversight for bioanalytical activities supporting the development of the companys therapeutic candidates. Reporting to the Vice President Clinical Pharmacology this role serves as the subject m

The Bioanalytical Expert is responsible for providing scientific leadership and operational oversight for bioanalytical activities supporting the development of the companys therapeutic candidates. Reporting to the Vice President Clinical Pharmacology this role serves as the subject m